Jackson CC, Medeiros LJ, Miranda RN (2010) 8p11 myeloproliferative syndrome: a review. Hum Pathol 41(4):461–476

Article  CAS  PubMed  Google Scholar 

Guasch G, Popovici C, Mugneret F, Chaffanet M, Pontarotti P, Birnbaum D, Pebusque MJ (2003) Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3). Blood 101(1):286–288

Article  CAS  PubMed  Google Scholar 

Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, Bejar R, Berti E, Busque L, Chan JKC et al (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia 36(7):1703–1719

Article  PubMed  PubMed Central  Google Scholar 

Tzankov A, Reichard KK, Hasserjian RP, Arber DA, Orazi A, Wang SA (2023) Updates on eosinophilic disorders. Virchows Arch 482(1):85–97

Article  CAS  PubMed  Google Scholar 

Saft L, Kvasnicka HM, Boudova L, Gianelli U, Lazzi S, Rozman M (2023) Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes: a workshop report with focus on novel entities and a literature review including paediatric cases. Histopathology 83(6):829–849

Article  PubMed  Google Scholar 

Chen M, Wang K, Cai X, Zhang X, Chao H, Chen S, Shen H, Wang Q, Zhang R (2021) Myeloid/lymphoid neoplasm with CEP110-FGFR1 fusion: an analysis of 16 cases show common features and poor prognosis. Hematology 26(1):153–159

Article  CAS  PubMed  Google Scholar 

Lv H, Hu S, Lu J, Zhai Q, Zhai Z, Du Z, Sun Y, Li J, He H, Wang Y (2018) Precursor T-lymphoblastic lymphoma associated with t(8;9)(p11.2;q33): a case report and review of the literature. Acta Haematol 139(3):176–182

Article  CAS  PubMed  Google Scholar 

Verstovsek S, Subbiah V, Masarova L, Yin CC, Tang G, Manshouri T, Asatiani E, Daver NG (2018) Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor. Ann Oncol 29(8):1880–1882

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou L, Fu W, Yuan Z, Hou J (2010) Complete molecular remission after interferon alpha treatment in a case of 8p11 myeloproliferative syndrome. Leuk Res 34(11):e306-307

Article  PubMed  Google Scholar 

Umino K, Fujiwara SI, Ikeda T, Toda Y, Ito S, Mashima K, Minakata D, Nakano H, Yamasaki R, Kawasaki Y et al (2018) Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement. Hematology 23(8):470–477

Article  CAS  PubMed  Google Scholar 

Hernandez-Boluda JC, Pereira A, Zinger N, Gras L, Martino R, Nikolousis E, Finke J, Chinea A, Rambaldi A, Robin M et al (2022) Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT. Bone Marrow Transplant 57(3):416–422

Article  CAS  PubMed  Google Scholar 

Verstovsek S, Kiladjian JJ, Vannucchi AM, Patel JL, Rambaldi A, Shomali WE, Oh ST, Usuki K, Harrison CN, Ritchie EK et al (2025) Pemigatinib for myeloid/lymphoid neoplasms with FGFR1 rearrangement. NEJM Evidence 4(9):EVIDoa2500017

Article  PubMed  Google Scholar 

Baer C, Muehlbacher V, Kern W, Haferlach C, Haferlach T (2018) Molecular genetic characterization of myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2. Haematologica 103(8):e348–e350

Article  CAS  PubMed  PubMed Central  Google Scholar 

Strati P, Tang G, Duose DY, Mallampati S, Luthra R, Patel KP, Hussaini M, Mirza AS, Komrokji RS, Oh S et al (2018) Myeloid/lymphoid neoplasms with FGFR1 rearrangement. Leuk Lymphoma 59(7):1672–1676

Article  CAS  PubMed  Google Scholar